The University of Oklahoma

Oklahoma City, Oklahoma 73117

1 studies enrolling now · 6 studies all time

What they study most

Aneurysm, Intracranial, Brain Aneurysm, Brain Glioblastoma, Fusiform Aneurysm, Hematologic, Immune, or Bone Marrow Disorders, Hemoglobinopathies, Hemolytic Anemia, Hemorrhagic Stroke, Iron Overload, Metabolic Disorders, Non-Squamous Non-Small Cell Lung Cancer, Non-malignant Disorders

Studies at this site

• The Use of p48/64 MW HPC Flow Modulation Device in the Treatment of Wide-necked Intracranial Aneurysms — Recruiting now
• Campath/Fludarabine/Melphalan Transplant Conditioning for Non-Malignant Diseases — Recruiting now
• Open-label Study Investigating of OKN-007 Combined With Temozolomide in Patients With Recurrent Glioblastoma — Completed
• Hydroxychloroquine in Individuals At-risk for Type 1 Diabetes Mellitus — Stopped early
• A Study to Evaluate the Safety and Pharmacology of DNIB0600A in Participants With Platinum-Sensitive Ovarian Cancer or Non-Squamous Non-small Cell Lung Cancer — Completed
• Study of Deferasirox Relative to Subcutaneous Deferoxamine in Sickle Cell Disease Patients — Completed